CureVac’s RNAntibody back
The publication in EMBO Molecular Medicine demonstrates CureVac’s proprietary mRNA technology enables antibody mediated therapies against infectious agents, toxins and tumors
scienceDISPLAY Dr. Bettina Danker update: 22.02.2022 flyer: english german Impressum Privacy/Datenschutz
